Business
DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board
40+ year healthcare career includes serving as Company Group Chairman at LifeScan, Inc., a multi-billion-dollar diabetes franchise previously owned by Johnson
About this update from Dariohealth Corp.
[{"type":"text","content":"40+ year healthcare career includes serving as Company Group Chairman at LifeScan, Inc., a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ)\n Scientific Advisory Board will help develop and execute the Company's strategic roadmap for refining, improving and expanding its digital therapeutics platform\n\n\nNEW YORK, Sept. 16, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established Scientific Advisory Board (SAB). \n\n \n \n \n \n \n \n\n \nEric Milledge has worked in the healthcare field for his entire career, with a focus on pharmaceuticals and medical devices. With more than 34 years at Johnson & Johnson (JNJ) in roles of increasing responsibility, he built a vast network of relationships across the healthcare landscape. \nAs president of Ortho McNeil Pharmaceutical, Eric led in the licensing and successful introduction of levofloxacin (antibiotic), tramadol (analgesic) and the commercialization of topamax (anticonvulsant), building a multi-billion dollar U.S. pharmaceutical business. Eric also served as Company Group Chairman for Johnson & Johnson Healthcare Systems which oversaw the negotiation and management of JNJ's medical device, diagnostic and pharmaceutical U.S. hospital contracts. Eric also served as Company Group Chairman of LifeScan Inc., the blood glucose division of JNJ. Under Eric's leadership, LifeScan Global Diabetes franchise experienced rapid organic and inorganic growth, including the acquisition of Inverness Medical Technology's Diabetes Care Products business. His leadership helped transform LifeScan into a global organization with thousands of employees and billions in annual revenues. \nAfter retiring from JNJ, Eric served as chairman for a number of medical device startup companies including chairman of Nfocus Neuromedical, Symetis SA and CeQur SA. Eric also served as an operating partner for Geneva based Endeavour Vision Growth, a medical device growth fund. In this newly-formed role at DarioHealth Corp., Eric will be responsible for building out an SAB with renowned physicians who both understand and champion the benefits of digital therapeutics in managing complex chronic conditions. \nEric and the future SAB mem...